Leading European vaccine products by market share 2015-2022

This statistic displays a projection of the top 3 European vaccine products and their respective market share worldwide in 2015 and 2022. Sanofi's influenza vaccine, Fluzone, is expected to accumulate 5.2 percent of the global market based on revenues by 2022. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.

Top 3 European vaccine products in 2015 and 2022 by market share

20142020
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

September 2016

Region

Europe

Survey time period

as of 2016

Supplementary notes

Market share based on revenues.

* Sanofi Pasteur MSD is a European joint venture between Merck & Co and Sanofi.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Immunization rates in the United Kingdom (UK) "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.